Pulmonary function and complications subsequent to autologous bone marrow transplantation

Area of Science:

• Hematology
• Pulmonology
• Oncology

Background:

• Autologous bone marrow transplantation (BMT) is a critical treatment for various hematologic and oncologic conditions.
• Pulmonary complications can significantly impact patient outcomes following BMT.

Purpose of the Study:

• To identify risk factors for early pulmonary complications after autologous BMT.
• To analyze the long-term effects of autologous BMT on pulmonary function.

Main Methods:

• Analysis of pulmonary complications in 158 adult patients undergoing autologous BMT.
• Pulmonary function tests conducted pre-BMT, at 6 and 12 months post-BMT, and annually thereafter.
• Evaluation of risk factors including total body irradiation (TBI) and pre-existing pulmonary conditions.

Main Results:

• The incidence of early pulmonary complications was 16%, with idiopathic interstitial pneumonitis in 11% of TBI-treated patients.
• Single-dose TBI was a major risk factor for early complications; pre-existing restrictive pulmonary disturbances and impaired diffusing capacity were also significant.
• Mild restrictive ventilatory dysfunction and impaired diffusing capacity were observed 6 months post-BMT in both TBI and non-TBI groups.
• TBI-treated patients showed persistent lung volume reduction (10%) compared to pre-BMT values, while non-TBI patients recovered within 2 years.

Conclusions:

• Single-dose TBI is a significant risk factor for early pulmonary complications post-autologous BMT.
• While most pulmonary function disturbances are mild and transient, TBI can lead to long-term reductions in lung volumes.
• Pre-transplant pulmonary status is crucial in predicting post-BMT pulmonary outcomes.